SIMBRINZA Rx

Select the drug indication to add to your list

SIMBRINZA

Glaucoma
Only 4 drugs may be compared at once

Generic Name and Formulations:

Brinzolamide 1%, brimonidine tartrate 0.2%; oph susp; contains benzalkonium chloride.

Select therapeutic use:

Indications for SIMBRINZA:

Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension.

Adults and Children:

<2yrs: contraindicated. ≥2yrs: 1 drop three times daily.

Contraindications:

Neonates and infants <2yrs.

Warnings/Precautions:

Sulfonamide allergy. Discontinue if serious systemic or hypersensitivity reactions occur. Increased risk of corneal edema in patients with low endothelium cell counts. Severe renal impairment (CrCl <30mL/min): not recommended. Hepatic impairment. Severe cardiovascular disease. Depression. Cerebral or coronary insufficiency. Raynaud’s phenomenon. Orthostatic hypotension. Thromboangitis obliterans. Acute angle-closure glaucoma. Remove soft contact lenses before use; may reinsert 15mins later. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Concomitant oral carbonic anhydrase inhibitors: not recommended. Caution with antihypertensives, cardiac glycosides, tricyclic antidepressants, MAOIs. Concomitant high-dose salicylate may produce acid-base and electrolyte alterations. May be potentiated by CNS depressants (eg, alcohol, opiates, barbiturates, sedatives, anesthetics). Separate administration of other oph drugs by ≥5 minutes.

Pharmacological Class:

Carbonic anhydrase inhibitor + alpha-2 agonist.

Adverse Reactions:

Blurred vision, eye irritation, dysgeusia, dry mouth, eye allergy.

How Supplied:

Susp—8mL

SIMBRINZA 8ml of 1%/0.2% eye droppers (Qty:1)

appx. price $145.00